CID 135980528

Itk inhibitor 2

Structural Information

Molecular Formula
C25H33N5O2
SMILES
C[C@@H](C(=O)N(C)C1=CC2=C(C=C1)C=C(N2)C3=NNC4=C3CCC(C4)(C)C)N5CCOCC5
InChI
InChI=1S/C25H33N5O2/c1-16(30-9-11-32-12-10-30)24(31)29(4)18-6-5-17-13-21(26-20(17)14-18)23-19-7-8-25(2,3)15-22(19)27-28-23/h5-6,13-14,16,26H,7-12,15H2,1-4H3,(H,27,28)/t16-/m0/s1
InChIKey
ZZZXGCPVQQOASC-INIZCTEOSA-N
Compound name
(2S)-N-[2-(6,6-dimethyl-1,4,5,7-tetrahydroindazol-3-yl)-1H-indol-6-yl]-N-methyl-2-morpholin-4-ylpropanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

54
Patents

435.26343 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 436.27071 206.0
[M+Na]+ 458.25265 209.8
[M-H]- 434.25615 211.3
[M+NH4]+ 453.29725 214.6
[M+K]+ 474.22659 205.1
[M+H-H2O]+ 418.26069 195.4
[M+HCOO]- 480.26163 214.1
[M+CH3COO]- 494.27728 212.0
[M+Na-2H]- 456.23810 202.0
[M]+ 435.26288 202.2
[M]- 435.26398 202.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe